This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Generation Bio Co.
Generation Bio Co., headquartered in the United States, is a pioneering biotechnology company focused on developing transformative gene therapies. Founded in 2016, the company has rapidly advanced its proprietary gene delivery platform, which aims to provide durable and potentially curative treatments for genetic diseases. With a strong emphasis on innovation, Generation Bio's core offerings include its unique non-viral gene therapy solutions, designed to overcome the limitations of traditional viral vectors. This approach positions the company at the forefront of the gene therapy industry, enabling it to address a wide range of genetic disorders. Notable achievements include significant funding rounds and strategic partnerships that have bolstered its market presence. As a leader in the biotechnology sector, Generation Bio is committed to advancing the future of medicine through its cutting-edge research and development initiatives.
DitchCarbon Score
How does Generation Bio Co.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Generation Bio Co.'s score of 29 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Generation Bio Co.'s reported carbon emissions
Generation Bio Co., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year. However, the company has set ambitious climate commitments aimed at achieving net-zero emissions. Generation Bio has outlined long-term targets to reach carbon neutrality in its operations by 2032 for both Scope 1 and Scope 2 emissions. These commitments reflect a growing trend within the industry to address climate change proactively. While specific reduction percentages have not been disclosed, the company's initiatives align with broader industry standards and expectations for sustainability. As part of its climate strategy, Generation Bio is committed to monitoring and reporting its progress towards these goals, ensuring transparency and accountability in its environmental impact. Overall, Generation Bio Co. is positioning itself as a responsible player in the biotechnology sector, with a clear focus on reducing its carbon footprint and contributing to global climate efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Generation Bio Co. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
